APO Research
Talk to an analyst

APO RESEARCH · REPORT

Huntington Disease Protein

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Huntington Disease Protein Industry Growth and Trends Forecast to 2032

22 December 2025100 pages

Choose your research edition.

Industry ResearchHuntington Disease Protein Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington Disease Protein Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Huntington Disease Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington Disease Protein Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington Disease Protein Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Huntington Disease Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington Disease Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Huntington Disease Protein include WAVE Life Sciences Ltd., Vybion, Inc., Voyager Therapeutics, Inc., UniQure N.V., Sangamo BioSciences, Inc., reMYND NV, nLife Therapeutics, S.L., Neurimmune Holding AG and Ionis Pharmaceuticals, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Huntington Disease Protein market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Huntington Disease Protein market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Huntington Disease Protein market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Huntington Disease Protein.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Huntington Disease Protein market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Huntington Disease Protein Market by Company

WAVE Life Sciences Ltd.

Vybion, Inc.

Voyager Therapeutics, Inc.

UniQure N.V.

Sangamo BioSciences, Inc.

reMYND NV

nLife Therapeutics, S.L.

Neurimmune Holding AG

Ionis Pharmaceuticals, Inc.

AFFiRiS AG

Huntington Disease Protein Segment by Type

P-301905

NLF-HD

NI-302

IONIS-HTTRx

Others

Huntington Disease Protein Segment by Application

Kennedy's Disease

Spinocerebellar Ataxia

Alzheimer's Disease

Others

Huntington Disease Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington Disease Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington Disease Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington Disease Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Huntington Disease Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Huntington Disease Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of P-301905 Table 2. Major Company of NLF-HD Table 3. Major Company of NI-302 Table 4. Major Company of IONIS-HTTRx Table 5. Major Company of Others Table 6. Global Huntington Disease Protein Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 8. Global Huntington Disease Protein Sales Market Share in Volume by Type (2021-2026) Table 9. Global Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 10. Global Huntington Disease Protein Sales Market Share in Value by Type (2021-2026) Table 11. Global Huntington Disease Protein Price by Type (2021-2026) & (US$/unit) Table 12. Global Huntington Disease Protein Sales by Type (2027-2032) & (k units) Table 13. Global Huntington Disease Protein Sales Market Share in Volume by Type (2027-2032) Table 14. Global Huntington Disease Protein Sales by Type (2027-2032) & (US$ Million) Table 15. Global Huntington Disease Protein Sales Market Share in Value by Type (2027-2032) Table 16. Global Huntington Disease Protein Price by Type (2027-2032) & (US$/unit) Table 17. North America Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 18. North America Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 20. Europe Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 24. Latin America Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Huntington Disease Protein Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Huntington Disease Protein Sales by Type (2021-2026) & (US$ Million) Table 27. Huntington Disease Protein Industry Trends Table 28. Huntington Disease Protein Industry Drivers Table 29. Huntington Disease Protein Industry Opportunities and Challenges Table 30. Huntington Disease Protein Industry Restraints Table 31. Global Huntington Disease Protein Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Huntington Disease Protein Revenue Market Share by Company (2021-2026) Table 33. Global Huntington Disease Protein Sales by Company (2021-2026) & (k units) Table 34. Global Huntington Disease Protein Sales Share by Company (2021-2026) Table 35. Global Huntington Disease Protein Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Huntington Disease Protein Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Huntington Disease Protein Major Company Production Sites and Headquarters Table 38. Global Huntington Disease Protein Company, Product Type & Application Table 39. Global Huntington Disease Protein Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Huntington Disease Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Huntington Disease Protein Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Huntington Disease Protein Sales by Region (2021-2026) & (k units) Table 44. Global Huntington Disease Protein Sales Market Share in Volume by Region (2021-2026) Table 45. Global Huntington Disease Protein Sales by Region (2021-2026) & (US$ Million) Table 46. Global Huntington Disease Protein Sales Market Share in Value by Region (2021-2026) Table 47. Global Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Huntington Disease Protein Sales by Region (2027-2032) & (k units) Table 49. Global Huntington Disease Protein Sales Market Share in Volume by Region (2027-2032) Table 50. Global Huntington Disease Protein Sales by Region (2027-2032) & (US$ Million) Table 51. Global Huntington Disease Protein Sales Market Share in Value by Region (2027-2032) Table 52. Global Huntington Disease Protein Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Huntington Disease Protein Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 55. Global Huntington Disease Protein Sales Market Share in Volume by Application (2021-2026) Table 56. Global Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 57. Global Huntington Disease Protein Sales Market Share in Value by Application (2021-2026) Table 58. Global Huntington Disease Protein Price by Application (2021-2026) & (US$/unit) Table 59. Global Huntington Disease Protein Sales by Application (2027-2032) & (k units) Table 60. Global Huntington Disease Protein Sales Market Share in Volume by Application (2027-2032) Table 61. Global Huntington Disease Protein Sales by Application (2027-2032) & (US$ Million) Table 62. Global Huntington Disease Protein Sales Market Share in Value by Application (2027-2032) Table 63. Global Huntington Disease Protein Price by Application (2027-2032) & (US$/unit) Table 64. North America Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 65. North America Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 67. Europe Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 71. Latin America Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Huntington Disease Protein Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Huntington Disease Protein Sales by Application (2021-2026) & (US$ Million) Table 74. WAVE Life Sciences Ltd. Company Information Table 75. WAVE Life Sciences Ltd. Business Overview Table 76. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio Table 78. WAVE Life Sciences Ltd. Recent Development Table 79. Vybion, Inc. Company Information Table 80. Vybion, Inc. Business Overview Table 81. Vybion, Inc. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Vybion, Inc. Huntington Disease Protein Product Portfolio Table 83. Vybion, Inc. Recent Development Table 84. Voyager Therapeutics, Inc. Company Information Table 85. Voyager Therapeutics, Inc. Business Overview Table 86. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio Table 88. Voyager Therapeutics, Inc. Recent Development Table 89. UniQure N.V. Company Information Table 90. UniQure N.V. Business Overview Table 91. UniQure N.V. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. UniQure N.V. Huntington Disease Protein Product Portfolio Table 93. UniQure N.V. Recent Development Table 94. Sangamo BioSciences, Inc. Company Information Table 95. Sangamo BioSciences, Inc. Business Overview Table 96. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio Table 98. Sangamo BioSciences, Inc. Recent Development Table 99. reMYND NV Company Information Table 100. reMYND NV Business Overview Table 101. reMYND NV Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. reMYND NV Huntington Disease Protein Product Portfolio Table 103. reMYND NV Recent Development Table 104. nLife Therapeutics, S.L. Company Information Table 105. nLife Therapeutics, S.L. Business Overview Table 106. nLife Therapeutics, S.L. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio Table 108. nLife Therapeutics, S.L. Recent Development Table 109. Neurimmune Holding AG Company Information Table 110. Neurimmune Holding AG Business Overview Table 111. Neurimmune Holding AG Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Neurimmune Holding AG Huntington Disease Protein Product Portfolio Table 113. Neurimmune Holding AG Recent Development Table 114. Ionis Pharmaceuticals, Inc. Company Information Table 115. Ionis Pharmaceuticals, Inc. Business Overview Table 116. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio Table 118. Ionis Pharmaceuticals, Inc. Recent Development Table 119. AFFiRiS AG Company Information Table 120. AFFiRiS AG Business Overview Table 121. AFFiRiS AG Huntington Disease Protein Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. AFFiRiS AG Huntington Disease Protein Product Portfolio Table 123. AFFiRiS AG Recent Development Table 124. North America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. North America Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 126. North America Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 127. North America Huntington Disease Protein Sales Forecast by Country (2027-2032) & (k units) Table 128. North America Huntington Disease Protein Sales Market Share Forecast by Country (2027-2032) Table 129. North America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Huntington Disease Protein Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Huntington Disease Protein Market Share by Country (2021-2026) Table 132. North America Huntington Disease Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Huntington Disease Protein Market Share Forecast by Country (2027-2032) Table 134. Europe Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Europe Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 136. Europe Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 137. Europe Huntington Disease Protein Sales Forecast by Country (2027-2032) & (k units) Table 138. Europe Huntington Disease Protein Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Huntington Disease Protein Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Huntington Disease Protein Market Share by Country (2021-2026) Table 142. Europe Huntington Disease Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Huntington Disease Protein Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 146. Asia-Pacific Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Huntington Disease Protein Sales Forecast by Country (2027-2032) & (k units) Table 148. Asia-Pacific Huntington Disease Protein Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Huntington Disease Protein Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Huntington Disease Protein Market Share by Country (2021-2026) Table 152. Asia-Pacific Huntington Disease Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Huntington Disease Protein Market Share Forecast by Country (2027-2032) Table 154. Latin America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Latin America Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 156. Latin America Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 157. Latin America Huntington Disease Protein Sales Forecast by Country (2027-2032) & (k units) Table 158. Latin America Huntington Disease Protein Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Huntington Disease Protein Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Huntington Disease Protein Market Share by Country (2021-2026) Table 162. Latin America Huntington Disease Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Huntington Disease Protein Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Huntington Disease Protein Sales by Country (2021-2026) & (k units) Table 166. Middle East and Africa Huntington Disease Protein Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Huntington Disease Protein Sales Forecast by Country (2027-2032) & (k units) Table 168. Middle East and Africa Huntington Disease Protein Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Huntington Disease Protein Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Huntington Disease Protein Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Huntington Disease Protein Market Share by Country (2021-2026) Table 172. Middle East and Africa Huntington Disease Protein Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Huntington Disease Protein Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Huntington Disease Protein Distributors List Table 177. Huntington Disease Protein Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Huntington Disease Protein Image Figure 2. Global Huntington Disease Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington Disease Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Huntington Disease Protein Sales (2021-2032) & (k units) Figure 5. P-301905 Image Figure 6. Global P-301905 Sales YoY Growth (2021-2032) & (k units) Figure 7. NLF-HD Image Figure 8. Global NLF-HD Sales YoY Growth (2021-2032) & (k units) Figure 9. NI-302 Image Figure 10. Global NI-302 Sales YoY Growth (2021-2032) & (k units) Figure 11. IONIS-HTTRx Image Figure 12. Global IONIS-HTTRx Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Huntington Disease Protein Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Huntington Disease Protein Market Share by Type 2025 VS 2032 Figure 17. North America Huntington Disease Protein Sales Market Share in Volume by Type in 2025 Figure 18. North America Huntington Disease Protein Sales Market Share in Value by Type in 2025 Figure 19. Europe Huntington Disease Protein Sales Market Share in Volume by Type in 2025 Figure 20. Europe Huntington Disease Protein Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Type in 2025 Figure 23. Latin America Huntington Disease Protein Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Huntington Disease Protein Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Huntington Disease Protein Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Huntington Disease Protein Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Kennedy's Disease Image Figure 30. Global Kennedy's Disease Sales YoY Growth (2021-2032) & (k units) Figure 31. Spinocerebellar Ataxia Image Figure 32. Global Spinocerebellar Ataxia Sales YoY Growth (2021-2032) & (k units) Figure 33. Alzheimer's Disease Image Figure 34. Global Alzheimer's Disease Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Huntington Disease Protein Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Huntington Disease Protein Market Share by Application 2025 VS 2032 Figure 39. North America Huntington Disease Protein Sales Market Share in Volume by Application in 2025 Figure 40. North America Huntington Disease Protein Sales Market Share in Value by Application in 2025 Figure 41. Europe Huntington Disease Protein Sales Market Share in Volume by Application in 2025 Figure 42. Europe Huntington Disease Protein Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Application in 2025 Figure 45. Latin America Huntington Disease Protein Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Huntington Disease Protein Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Huntington Disease Protein Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Application in 2025 Figure 49. North America Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Huntington Disease Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Huntington Disease Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Huntington Disease Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Huntington Disease Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Huntington Disease Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Huntington Disease Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Huntington Disease Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Huntington Disease Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Huntington Disease Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Huntington Disease Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Huntington Disease Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Huntington Disease Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Huntington Disease Protein Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Huntington Disease Protein Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Huntington Disease Protein Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Huntington Disease Protein Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Huntington Disease Protein Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Huntington Disease Protein Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • P-301905
  • NLF-HD
  • NI-302
  • IONIS-HTTRx
  • Others
Applications
  • Kennedy's Disease
  • Spinocerebellar Ataxia
  • Alzheimer's Disease
  • Others
Companies covered
  • WAVE Life Sciences Ltd.
  • Vybion, Inc.
  • Voyager Therapeutics, Inc.
  • UniQure N.V.
  • Sangamo BioSciences, Inc.
  • reMYND NV
  • nLife Therapeutics, S.L.
  • Neurimmune Holding AG
  • Ionis Pharmaceuticals, Inc.
  • AFFiRiS AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Huntington Disease Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Huntington Disease Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Huntington Disease Protein Market by Type
  6. 1.3.1 P-301905
  7. 1.3.2 NLF-HD
  8. 1.3.3 NI-302
  9. 1.3.4 IONIS-HTTRx
  10. 1.3.5 Others
  11. 1.4 Global Huntington Disease Protein Market Size by Type
  12. 1.4.1 Global Huntington Disease Protein Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Huntington Disease Protein Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Huntington Disease Protein Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Huntington Disease Protein Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Huntington Disease Protein Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Huntington Disease Protein Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Huntington Disease Protein Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Huntington Disease Protein Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Huntington Disease Protein Industry Trends
  2. 2.2 Huntington Disease Protein Industry Drivers
  3. 2.3 Huntington Disease Protein Industry Opportunities and Challenges
  4. 2.4 Huntington Disease Protein Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Huntington Disease Protein Revenue (2021-2026)
  2. 3.2 Global Top Players by Huntington Disease Protein Sales (2021-2026)
  3. 3.3 Global Top Players by Huntington Disease Protein Price (2021-2026)
  4. 3.4 Global Huntington Disease Protein Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Huntington Disease Protein Major Company Production Sites & Headquarters
  6. 3.6 Global Huntington Disease Protein Company, Product Type & Application
  7. 3.7 Global Huntington Disease Protein Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Huntington Disease Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Huntington Disease Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Huntington Disease Protein Tier 1, Tier 2, and Tier 3
4 Huntington Disease Protein Regional Status and Outlook
  1. 4.1 Global Huntington Disease Protein Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Huntington Disease Protein Historic Market Size by Region
  3. 4.2.1 Global Huntington Disease Protein Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Huntington Disease Protein Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Huntington Disease Protein Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Huntington Disease Protein Forecasted Market Size by Region
  7. 4.3.1 Global Huntington Disease Protein Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Huntington Disease Protein Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Huntington Disease Protein Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Huntington Disease Protein by Application
  1. 5.1 Huntington Disease Protein Market by Application
  2. 5.1.1 Kennedy's Disease
  3. 5.1.2 Spinocerebellar Ataxia
  4. 5.1.3 Alzheimer's Disease
  5. 5.1.4 Others
  6. 5.2 Global Huntington Disease Protein Market Size by Application
  7. 5.2.1 Global Huntington Disease Protein Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Huntington Disease Protein Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Huntington Disease Protein Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Huntington Disease Protein Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Huntington Disease Protein Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Huntington Disease Protein Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Huntington Disease Protein Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Huntington Disease Protein Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 WAVE Life Sciences Ltd.
  2. 6.1.1 WAVE Life Sciences Ltd. Company Information
  3. 6.1.2 WAVE Life Sciences Ltd. Business Overview
  4. 6.1.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 WAVE Life Sciences Ltd. Huntington Disease Protein Product Portfolio
  6. 6.1.5 WAVE Life Sciences Ltd. Recent Developments
  7. 6.2 Vybion, Inc.
  8. 6.2.1 Vybion, Inc. Company Information
  9. 6.2.2 Vybion, Inc. Business Overview
  10. 6.2.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Vybion, Inc. Huntington Disease Protein Product Portfolio
  12. 6.2.5 Vybion, Inc. Recent Developments
  13. 6.3 Voyager Therapeutics, Inc.
  14. 6.3.1 Voyager Therapeutics, Inc. Company Information
  15. 6.3.2 Voyager Therapeutics, Inc. Business Overview
  16. 6.3.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Voyager Therapeutics, Inc. Huntington Disease Protein Product Portfolio
  18. 6.3.5 Voyager Therapeutics, Inc. Recent Developments
  19. 6.4 UniQure N.V.
  20. 6.4.1 UniQure N.V. Company Information
  21. 6.4.2 UniQure N.V. Business Overview
  22. 6.4.3 UniQure N.V. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 UniQure N.V. Huntington Disease Protein Product Portfolio
  24. 6.4.5 UniQure N.V. Recent Developments
  25. 6.5 Sangamo BioSciences, Inc.
  26. 6.5.1 Sangamo BioSciences, Inc. Company Information
  27. 6.5.2 Sangamo BioSciences, Inc. Business Overview
  28. 6.5.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sangamo BioSciences, Inc. Huntington Disease Protein Product Portfolio
  30. 6.5.5 Sangamo BioSciences, Inc. Recent Developments
  31. 6.6 reMYND NV
  32. 6.6.1 reMYND NV Company Information
  33. 6.6.2 reMYND NV Business Overview
  34. 6.6.3 reMYND NV Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 reMYND NV Huntington Disease Protein Product Portfolio
  36. 6.6.5 reMYND NV Recent Developments
  37. 6.7 nLife Therapeutics, S.L.
  38. 6.7.1 nLife Therapeutics, S.L. Company Information
  39. 6.7.2 nLife Therapeutics, S.L. Business Overview
  40. 6.7.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 nLife Therapeutics, S.L. Huntington Disease Protein Product Portfolio
  42. 6.7.5 nLife Therapeutics, S.L. Recent Developments
  43. 6.8 Neurimmune Holding AG
  44. 6.8.1 Neurimmune Holding AG Company Information
  45. 6.8.2 Neurimmune Holding AG Business Overview
  46. 6.8.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Neurimmune Holding AG Huntington Disease Protein Product Portfolio
  48. 6.8.5 Neurimmune Holding AG Recent Developments
  49. 6.9 Ionis Pharmaceuticals, Inc.
  50. 6.9.1 Ionis Pharmaceuticals, Inc. Company Information
  51. 6.9.2 Ionis Pharmaceuticals, Inc. Business Overview
  52. 6.9.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product Portfolio
  54. 6.9.5 Ionis Pharmaceuticals, Inc. Recent Developments
  55. 6.10 AFFiRiS AG
  56. 6.10.1 AFFiRiS AG Company Information
  57. 6.10.2 AFFiRiS AG Business Overview
  58. 6.10.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AFFiRiS AG Huntington Disease Protein Product Portfolio
  60. 6.10.5 AFFiRiS AG Recent Developments
7 North America by Country
  1. 7.1 North America Huntington Disease Protein Sales by Country
  2. 7.1.1 North America Huntington Disease Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Huntington Disease Protein Sales by Country (2021-2026)
  4. 7.1.3 North America Huntington Disease Protein Sales Forecast by Country (2027-2032)
  5. 7.2 North America Huntington Disease Protein Market Size by Country
  6. 7.2.1 North America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Huntington Disease Protein Market Size by Country (2021-2026)
  8. 7.2.3 North America Huntington Disease Protein Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Huntington Disease Protein Sales by Country
  2. 8.1.1 Europe Huntington Disease Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Huntington Disease Protein Sales by Country (2021-2026)
  4. 8.1.3 Europe Huntington Disease Protein Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Huntington Disease Protein Market Size by Country
  6. 8.2.1 Europe Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Huntington Disease Protein Market Size by Country (2021-2026)
  8. 8.2.3 Europe Huntington Disease Protein Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Huntington Disease Protein Sales by Country
  2. 9.1.1 Asia-Pacific Huntington Disease Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Huntington Disease Protein Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Huntington Disease Protein Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Huntington Disease Protein Market Size by Country
  6. 9.2.1 Asia-Pacific Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Huntington Disease Protein Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Huntington Disease Protein Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Huntington Disease Protein Sales by Country
  2. 10.1.1 South America Huntington Disease Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Huntington Disease Protein Sales by Country (2021-2026)
  4. 10.1.3 South America Huntington Disease Protein Sales Forecast by Country (2027-2032)
  5. 10.2 South America Huntington Disease Protein Market Size by Country
  6. 10.2.1 South America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Huntington Disease Protein Market Size by Country (2021-2026)
  8. 10.2.3 South America Huntington Disease Protein Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Huntington Disease Protein Sales by Country
  2. 11.1.1 Middle East and Africa Huntington Disease Protein Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Huntington Disease Protein Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Huntington Disease Protein Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Huntington Disease Protein Market Size by Country
  6. 11.2.1 Middle East and Africa Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Huntington Disease Protein Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Huntington Disease Protein Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Huntington Disease Protein Value Chain Analysis
  2. 12.1.1 Huntington Disease Protein Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Huntington Disease Protein Production Mode & Process
  7. 12.2 Huntington Disease Protein Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Huntington Disease Protein Distributors
  10. 12.2.3 Huntington Disease Protein Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst